CERE
Cerevel Therapeutics Holdings, Inc.
Director Marijn E Dekkers sold $6.9M of Cerevel Therapeutics Holdings, Inc.
Sold$6,886,000
$34.43Price
200,000Shares
−32%Stake
What CERE did after the filing
- The stock from Tue, Jun 20 close, $34.17
- −22.9%
- S&P 500, same days
- +3.0%
Measured over 30 trading days, to the Aug 2 close.
Traded Thu, Jun 15. Filed Tue, Jun 20, 12:56 PM ET, during the session. Returns use the Jun 20 close and the Aug 2 close. Not investment advice.